|
Catalog Number 03.702.150S |
Device Problem
Break (1069)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/07/2022 |
Event Type
malfunction
|
Event Description
|
Device report from (b)(6) reports an event as follows: it was reported that during an open reduction internal fixation surgery for a trochanter on (b)(6) 2022, a traumacem syringe was broken.The events took place in sequence as follows: after cement mixing, two white syringes and the cannula were filled with cement without problems.The blue syringe was filled smoothly up to the second syringe.It was confirmed that a broken piece of the tip of the second syringe was left at the connection, and it became impossible to connect the remaining syringes.The amount of cement filled in 1.And 2.Was determined to be sufficient, and the procedure for cement injection in the femoral head was started.When connecting the blue syringe to the cannula, it was difficult to connect.After connecting, the syringe was too stiff to inject cement.The syringe was removed and checked, but it was confirmed that the cement was not hardened yet and came out smoothly from the syringe.The tip of the blue syringe was broken and stuck in the cannula, and it was impossible to insert the pusher.The broken tip of the blue syringe was connected to the cannula and less than 1 ml of cement was injected into the bone head; the procedure was abandoned thereafter.Transverse locking screw and end cap inserted.The surgery was completed successfully with less than thirty minutes delay.This report is for a traumacem(tm) v+ syringe kit ¿ sterile.This is report 1 of 1 for (b)(4).
|
|
Manufacturer Narrative
|
Additional narrative: complainant part is not expected to be returned for manufacturer review/investigation.Reporter is a synthes employee.The investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H4 device history: part: 03.702.150s; lot:1102564; release to warehouse date: 21 october 2021; manufacturing site: werk selzach logistik; supplier: (b)(4).A manufacturing record evaluation was performed for the finished article lot and no non-conformances were identified.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Search Alerts/Recalls
|
|
|